TrialScientific reports2023

Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.

Zahid Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.